Transcriptomics Technologies Market, By Technology (Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics), and By Region (

Transcriptomics Technologies Market, By Technology (Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Transcriptomics the study of structures and functions of transcript molecules. Transcripts comprise all types of ribonucleic acid (RNA) molecules namely, messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules. Increasing approval and new product launch of microarrays is expected to propel growth of the global transcriptomics technologies market over the forecast period. Furthermore, Increasing prevalence of cardiovascular diseases is expected to offer lucrative growth opportunities for players in the global transcriptomics technologies market.
Key features of the study:
This report provides in-depth analysis of the Global Transcriptomics Technologies market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Transcriptomics Technologies market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Ethicon, Inc. (Johnson & Johnson), Covidien Plc. (Medtronic Plc.), B. Braun Melsungen AG, Medicon EG, Erbe Elektromedizin GmbH, Conmed Corporation, Carefusion, and Cardinal Health.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Transcriptomics Technologies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Transcriptomics Technologies market
Detailed Segmentation:
Global Transcriptomics Technologies Market, By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
Global Transcriptomics Technologies Market, By Application:
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
Global Transcriptomics Technologies Market, By Region:
North America
By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
By Application
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
By Country
U.S.
Canada
Latin America
By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
By Application
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
By Application
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
By Application
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
By Application
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Technology:
Microarrays
PCR
Gene Regulation Technologies
Next Generation Sequencing
By Application
Clinical Diagnostics
Drug Discovery & Research
Bioinformatics
Comparative Transcriptomics
By Country
North Africa
Central Africa
South Africa
Company Profiles
Affymetrix, Inc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Life Technologies Corporation
LC Sciences, LLC
Qiagen N.V.
“*” marked represents similar segmentation in other categories in the respective section.